Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study

被引：0
|
作者：
Yu-Cheol Lim
Eui-Kyung Lee
Mi-Hai Park
机构：
[1] Sungkyunkwan University,School of Pharmacy
来源：
Lipids in Health and Disease | / 22卷
关键词：
Drug switching; Generic drug; Atorvastatin; Low-density lipoprotein-cholesterol; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] DIETARY DEFICIENCY OF VITAMIN-E AND SELENIUM INCREASES RAT LOW-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS
    NICHOLAS, C
    PAVULURI, S
    STONE, WL
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 1058 - 1058
  • [22] COMPARISON OF PLASMA SMALL DENSE LOW-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS IN AMERICANS AND JAPANESE IN FRAMINGHAM AND FUKUOKA
    Ai, M.
    Koga, T.
    Furusyo, N.
    Otokozawa, S.
    Asztalos, B.
    White, C.
    Demissie-Banjaw, S.
    Cupples, La
    Nakajima, K.
    Hayashi, J.
    Schaefer, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [23] Genetic factors that contribute to interindividual variations in plasma low density lipoprotein-cholesterol levels - Discussion
    Zechner, R
    Hobbs, HH
    Chakravarti, A
    Weiss, KM
    Edwards, JH
    Scriver, CR
    Templeton, AR
    VARIATION IN THE HUMAN GENOME, 1996, 197 : 206 - 210
  • [24] Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting
    Fox, Kathleen M.
    Gandhi, Sanjay K.
    Ohsfeldt, Robert L.
    Davidson, Michael H.
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (10): : S270 - S275
  • [25] Influence of apolipoprotein E phenotype on changes in plasma levels of low-density lipoprotein-cholesterol and apolipoprotein B due to the effects of simvastatin
    Kobayashi, T
    Homma, Y
    Handa, S
    Nakamura, H
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1998, 8 (06) : 358 - 364
  • [26] Omega-3 fatty acid ethyl esters improve low-density lipoprotein subclasses without increasing low-density lipoprotein-cholesterol levels: A phase 4, randomized study
    Masuda, Daisaku
    Miyata, Yuko
    Matsui, Shingo
    Yamashita, Shizuya
    ATHEROSCLEROSIS, 2020, 292 : 163 - 170
  • [27] Changes and Variability in High Levels of Low-Density Lipoprotein Cholesterol Among Children
    Freedman, David S.
    Wang, Y. Claire
    Dietz, William H.
    Xu, Ji-Hua
    Srinivasan, Sathanur R.
    Berenson, Gerald S.
    PEDIATRICS, 2010, 126 (02) : 266 - 273
  • [28] Attainment of Low-Density Lipoprotein Cholesterol Goals in Statin Treated Patients: Real-World Evidence From Australia
    Talic, Stella
    Marquina, Clara
    Zomer, Ella
    Ofori-Asenso, Richard
    Petrova, Marjana
    Vargas-Torres, Sandra
    Abushanab, Dina
    Wolfe, Rory
    Lybrand, Sean
    Thomson, David
    Stratton, Giles
    Liew, Danny
    Ademi, Zanfina
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (07)
  • [29] Bridging the Gap: Insights from the AIZANOI Study on Low-Density Lipoprotein-Cholesterol Management in Turkiye
    Kayikcioglu, Meral
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (06): : 283 - 285
  • [30] Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA)
    Rikhi, Rishi
    Hammoud, Aziz
    Ashburn, Nicklaus
    Snavely, Anna C.
    Michos, Erin D.
    Chevli, Parag
    Tsai, Michael Y.
    Herrington, David
    Shapiro, Michael D.
    ATHEROSCLEROSIS, 2022, 363 : 102 - 108
12345